Comparative Pathological Analysis of Herpes Simplex Virus Type 2 Infection in BALB/c Mice by Different Routes

doi:10.3969/j.issn.1674-5817.2020.01.003

Abstract

Abstract: Objective To compare the pathological changes of BALB/c mice infected with herpes simplex virus type 2 (HSV-2) by different routes. Method BALB/c mice were challenged with HSV-2 by three different ways , namely, through vagina, nasal cavity and cornea. The clinical manifestations of mice and the pathological changes of challenged site and nerve tissue were observed, and the viral load in nerve tissue was detected. Result There was no overt symptom in the nasal cavity of which the survival rate was 27.27% at the end of observation period. The vaginal group showed different degrees of vulvitis and weight loss and other symptoms, and the survival rate of the mice on day 8 was 0. Corneal group mice showed different degrees of keratitis, the survival rate at the end of observation period was still 63.64%. The results of pathological changes showed that there were obvious pathological changes in the brain tissue of nasal group mice. Both the vagina group and the cornea group mice showed significant pathological changes in the offending sites, and the brain and spinal cord of the vagina group mice showed obvious pathological changes. The results of viral load detection in the nerve tissue showed that, compared with control group, the viral load of HSV-2 in the brain and spinal cord of the three experimental groups was significantly increased with the increase of infection time. Conclusions The infection of HSV-2 by three different ways can cause different pathological changes in mice. This study provides a theoretical basis for the study of the pathogenesis of nervous system disease induced by HSV-2 infection.

Key words: Herpes simplex virus type 2(HSV-2), BALB/c mice, Pathological analysis, Infection route

CLC Number:

Q95-33

CHENG Jishuai, MOU Tangwei, LIU Lei, WU Huaye, LI Qihan. Comparative Pathological Analysis of Herpes Simplex Virus Type 2 Infection in BALB/c Mice by Different Routes[J]. Laboratory Animal and Comparative Medicine, 2020, 40(1): 15-21.

References

[1] 樊建勇, 赵阳, 杨慧兰. 单纯疱疹病毒的潜伏、复发感染与防治[J]. 中国医学文摘: 皮肤科学, 2017, 34(1):9-17.
[2] Johnston C, Corey L.Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract[J]. Clin Microbiol Rev, 2016, 29(1):149-161.
[3] Meyding-Lamadé U, Strank C.Herpes virus infections of the central nervous system in immunocompromised patients[J]. Ther Adv Neurol Disord, 2012, 5(5):279-296.
[4] Looker KJ, Maqaret AS, Turner KM, et al.Correction: Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012[J]. PLoS One, 2015, 10(1): e114989.
[5] Tronstein E, Johnston C, Huang ML, et al.Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection[J]. JAMA, 2011,305(14):1441-1449.
[6] Freeman EE, WEISS HA, Glynn JR, et al.Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies[J]. AIDS, 2006, 20(1):73-83.
[7] 杨荷丹, 蒋娟. 单纯疱疹病毒感染的复发机制与治疗的研究进展[J]. 中国麻风皮肤病杂志, 2018, 34(11):694-697.
[8] Nicoll MP, Proenca JT, Efstathiou S.The molecular basis of herpes simplex virus latency[J]. FEMS Microbiol Rev, 2012, 36(3):684-705.
[9] Efstathiou S, Preston CM.Towards an understanding of the molecular basis of herpes simplex virus latency[J]. Virus Res, 2005, 111(2):108-119.
[10] 候亚林, 杜立行, 欧柏生, 等. 参芪止疱颗粒抗HSV-2的体外实验研究[J]. 陕西中医, 2018, 39(1):10-13.
[11] Parr MB, Parr EL.Protective immunity against HSV-2 in the mouse vagina[J]. J Reprod Immunol, 1997, 36(1-2):77-92.
[12] Parr MB, Parr EL.Vaginal immunity in the HSV-2 mouse model[J]. Int Rev Immunol, 2003, 22:43-63.
[13] McDermott MR, Smiley JR, Leslie P, et al. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2[J]. J Virol, 1984, 51(3):747-753.
[14] Lo M, Zhu J, Hanson SG, et al.Acute infection and subsequent subclinical reactivation of herpes simplex virus-2 after vaginal inoculation of rhesus macaques[J]. J Virol, 2019, 93(2):e01574-18.
[15] Bernstein DI, Cardin RD, Pullum DA, et al.Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials[J]. PLoS One, 2019, 14(3):e0213401.
[16] Awasthi S, Hook LM, Shaw CE, et al.An HSV-2 trivalent vaccine is immunogenic in rhesus macaques and highly efficacious in guinea pigs[J]. PLoS Pathog, 2017, 13(1): e1006141.
[17] 杜丽芳, 张晓焕, 高华, 等. 检测Ⅱ型单纯疱疹病毒DNA拷贝的real-time qPCR方法的建立及其应用[J]. 中国生物制品学杂志, 2016, 29(10):1082-1086.
[18] Burrel S, Boutolleau D, Ryu D, et al.Ancient Recombination Events between Human Herpes Simplex Viruses[J]. Mol Biol Evol, 2017, 34(7):1713-1721.
[19] 陈平, 马良, 刘二战, 等.不同人群感染单纯疱疹病毒2型的流行病学特点[J]. 国际生物制品学杂志, 2015, 38(4):189-192.
[20] Awasthi S, Mahairas GG, Shaw CE, et al.A dual-modality Herpes simplex virus 2 vaccine for preventing genital herpes by using glycoprotein C and D subunit antigens to induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T Cell immunogens[J]. J Virol, 2015, 89(16):8497-8509.
[21] 范胜涛, 冯敏, 徐兴丽, 等. 1型单纯疱疹病毒经不同途径感染小鼠建立病理模型的比较分析[J]. 中国生物制品学杂志, 2017, 5(5):472-476.